CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes
about
Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell VaccinationInterest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer VaccineCharacteristics of tertiary lymphoid structures in primary cancersRestoring Lost Anti-HER-2 Th1 Immunity in Breast Cancer: A Crucial Role for Th1 Cytokines in Therapy and PreventionTrends and advances in tumor immunology and lung cancer immunotherapyAdjuvants for peptide-based cancer vaccinesRole of interferon-γ and cytotoxic T lymphocytes in intraocular tumor rejection.Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunctionCognate antigen engagement on parenchymal cells stimulates CD8+ T cell proliferation in situ.Re-adapting T cells for cancer therapy: from mouse models to clinical trials.Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in gliomaAlpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients.The distribution and function of human memory T cell subsets in lung cancerIDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanomaMELOE-1 antigen contains multiple HLA class II T cell epitopes recognized by Th1 CD4+ T cells from melanoma patients.Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help.Protective CD8 memory T cell responses to mouse melanoma are generated in the absence of CD4 T cell helpMagnetic-activated cell sorting of TCR-engineered T cells, using tCD34 as a gene marker, but not peptide-MHC multimers, results in significant numbers of functional CD4+ and CD8+ T cellsIdentification of immunogenic LY6K long peptide encompassing both CD4(+) and CD8(+) T-cell epitopes and eliciting CD4(+) T-cell immunity in patients with malignant diseaseThe present status and future prospects of peptide-based cancer vaccines.Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumoursTumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells.CD4+ T cells play a critical role in the generation of primary and memory antitumor immune responses elicited by SA-4-1BBL and TAA-based vaccines in mouse tumor models.IL-17-dependent, IFN-gamma-independent tumor rejection is mediated by cytotoxic T lymphocytes and occurs at extraocular sites, but is excluded from the eye.Profile of differentially expressed intratumoral cytokines to predict the immune-polarizing side effects of tamoxifen in breast cancer treatmentCancer immunotherapy using novel tumor-associated antigenic peptides identified by genome-wide cDNA microarray analyses.T-cell subsets in peripheral blood and tumors of patients treated with oncolytic adenoviruses.Nab2 regulates secondary CD8+ T-cell responses through control of TRAIL expression.Infiltrating lymphocytes and human papillomavirus-16--associated oropharyngeal cancer.Immunoglobulin Fc fragment tagging allows strong activation of endogenous CD4 T cells to reshape the tumor milieu and enhance the antitumor effect of lentivector immunization.Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regressionProgressive loss of anti-HER2 CD4(+) T-helper type 1 response in breast tumorigenesis and the potential for immune restorationUnique features of antiviral immune system of the vaginal mucosaTargeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice.Polyfunctional CD4⁺ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy.Tumor-Unrelated CD4 T Cell Help Augments CD134 plus CD137 Dual Costimulation Tumor TherapyThe Tumor Antigen NY-ESO-1 Mediates Direct Recognition of Melanoma Cells by CD4+ T Cells after Intercellular Antigen Transfer.Identification of novel Lck-derived T helper epitope long peptides applicable for HLA-A2(+) cancer patients as cancer vaccineImmunotherapy of human papilloma virus induced diseaseIdentification of glypican-3-derived long peptides activating both CD8(+) and CD4(+) T cells; prolonged overall survival in cancer patients with Th cell response
P2860
Q26765345-5E687EE2-604E-4693-99F4-E822E603FE16Q26782583-83A3B398-E629-4BB6-86F1-09D4B598E401Q27012852-74D13D8C-C317-49A7-86CE-7055B3E73406Q28067145-F8D740F7-DBE7-45E3-8414-3360596745D9Q28067674-1775A49E-8207-4278-8FBF-AD2A36042A87Q28072236-BA4FE12B-7047-4F69-AD55-5FB1AA294A76Q30357718-0AAAF8CF-7F8F-47DE-BC12-A812E0861DBBQ30583272-949A7C3F-42C3-4D2E-8417-33A98B607E0CQ33571993-D8131E3D-0371-4592-96E0-B1E708FDD7BFQ33588711-207E6E68-211B-422B-8CC1-387C57A5B6ACQ33613584-700A9FD1-5B73-4219-AF7C-994ED0E2E5A6Q33614172-252E0ABB-6E9B-4460-8CE3-940B0ACAD3EDQ33715287-172B4156-F956-41BE-916C-B114F95384E5Q33849567-088D32C2-B9A6-4571-BAC3-D6289ECA5477Q34034978-7CC708A9-D0F9-470F-A23E-908F29C34BB2Q34041058-5E2879FF-6585-49F2-8756-5C22451CCD1EQ34064488-8BE5CFE8-DB41-43AB-A27E-3A35EC15414AQ34370215-6C0BC35E-4614-4538-8B1E-0CBACBCDF258Q34372937-CDA24112-D175-4F5A-AD6D-C59134FEC806Q34528638-27CF7708-9761-49E3-98D6-E8415FC26A6AQ34744875-95616542-6AAB-476D-9700-EF0E00FB6AEEQ34823085-C3FAF323-8CC4-4127-9EFF-CDA7AEA01060Q34996924-EF866ADF-230C-407F-AF67-327B0CAE9CACQ35269684-78A210FD-8D1C-4C25-8101-9722076D099DQ35402584-7C12157D-1033-41D5-8071-14D91C68ED49Q35569528-95E4966B-0DCB-4DF2-9B4E-EEE7E484EAE1Q35594838-0A242423-2AD3-4AC7-BACF-585A665ED534Q35692033-680B7216-5D29-46FC-A0AC-E01EAD1476E7Q35913813-816A1EA1-AB39-4F87-951F-AE7774CA8015Q35982675-A6FC6B80-8ABF-43DF-888D-7AA26F7E08FBQ36060263-B30C8B0C-A12C-464F-92AB-353B1EBC133AQ36107949-2618A804-3D2E-4B9A-8F6A-B104BA3E4143Q36177229-D5E53E46-45A9-4A00-AFAF-9C694DEF00B9Q36245506-9657E4B4-9B4E-41BD-9050-C66F37BF7F35Q36249440-AFAA3F54-29B7-4029-9884-0784FD887586Q36349514-AC69EF3C-D51C-423A-98AD-244033D43A4AQ36382255-3BF8BC6F-0931-4EE4-9297-848211EEFC1CQ36467443-18ED4997-0233-493F-BEC3-4C6B49A0D712Q36541008-9D749921-3764-43F1-81F7-38F4FCC51CB3Q36597336-C99718A9-4345-44D2-ACA8-0535E24DD517
P2860
CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
CD4+ T-cell help in the tumor ...... function of CD8+ T lymphocytes
@en
CD4+ T-cell help in the tumor ...... function of CD8+ T lymphocytes
@nl
type
label
CD4+ T-cell help in the tumor ...... function of CD8+ T lymphocytes
@en
CD4+ T-cell help in the tumor ...... function of CD8+ T lymphocytes
@nl
prefLabel
CD4+ T-cell help in the tumor ...... function of CD8+ T lymphocytes
@en
CD4+ T-cell help in the tumor ...... function of CD8+ T lymphocytes
@nl
P2860
P1433
P1476
CD4+ T-cell help in the tumor ...... function of CD8+ T lymphocytes
@en
P2093
Linda A Sherman
P2860
P304
P356
10.1158/0008-5472.CAN-10-1322
P407
P577
2010-10-12T00:00:00Z